Patients with bicuspid aortic stenosis who receive transcatheter aortic valve replacement (TAVR) may require subsequent valve interventions in their lifetime; however, the feasibility of redo-TAVR in ...

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...

In patients greater than age 65, more than 90% of aortic stenosis involves trileaflet valves which have developed heavy calcification. [5] In these instances the calcium deposits are thought to ...

Electronic provider notification led to more aortic valve replacement procedures after a diagnosis of severe aortic stenosis vs. usual care. There was a trend toward the intervention reducing ...

Aortic stenosis is the most common valvular lesion in patients above the age of 65. The etiology, presentation, and management of aortic stenosis differs in the elderly compared to younger ...

Edwards Lifesciences' first-quarter 2025 performance benefits from its differentiated portfolio of therapies to treat ...

The US FDA has granted approval for the use of Medtronic’s disposable Simplera Sync sensor with the MiniMed 780G system.

OBJECTIVE To ascertain the surgical risk and long term outcome of patients over 80 years old undergoing aortic valve replacement (AVR). DESIGN Consecutive cases with respective case note audit and a ...